Young biotech Codagenix just secured $3 million in funding to advance its live-attenuated RSV vaccine candidate.

Affluent regions with more new moms are most likely to be spawning grounds for antivaccine tweets, a five-year study found.

A large-scale phase 3 study shows that Merck's Gardasil 9 vaccine protects against HPV-related cancers for at least six years.

In a temporary break from its corporate drama, Sinovac posted positive topline data from a phase 3 study of its chickenpox vaccine.

Inovio and GeneOne have started a clinical study of their MERS vaccine in South Korea, where the virus took 36 lives in a 2015 outbreak.

Johnson & Johnson and a U.S. development agency are zeroing in on pandemic flu in a novel deal focusing on vaccine and flu drug candidates.

Secretive Moderna shared a new peek into its infectious disease vaccines efforts Thursday.

A phase 3 study shows that Seqirus' MF59-adjuvanted quadrivalent flu vaccine provides better protection in those younger than two years old.

Infectious Diseases